An international, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid unresponsive cancer-related neuropathic pain: Phase III trial
GA ID:
Agency:
National Health and Medical Research Council (NHMRC)
Publish Date:
20-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020
to
31-Dec-2024
Value (AUD):
$978,610.00
Recipient Name:
University of Technology Sydney
Last Updated:
20-Dec-2019 9:10 am (ACT Local Time)